chr3-179576616-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004301.5(ACTL6A):c.572-4A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000087 in 1,608,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004301.5 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACTL6A | NM_004301.5 | c.572-4A>G | splice_region_variant, intron_variant | ENST00000429709.7 | NP_004292.1 | |||
ACTL6A | NM_177989.4 | c.446-4A>G | splice_region_variant, intron_variant | NP_817126.1 | ||||
ACTL6A | NM_178042.4 | c.446-4A>G | splice_region_variant, intron_variant | NP_829888.1 | ||||
LOC124909462 | XR_007096181.1 | n.85+146T>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACTL6A | ENST00000429709.7 | c.572-4A>G | splice_region_variant, intron_variant | 1 | NM_004301.5 | ENSP00000397552.2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152250Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 250018Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135422
GnomAD4 exome AF: 0.00000824 AC: 12AN: 1456546Hom.: 0 Cov.: 30 AF XY: 0.00000552 AC XY: 4AN XY: 724966
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152250Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74390
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2021 | The c.572-4A>G intronic alteration consists of a A to G substitution 4 nucleotides before exon 7 of the ACTL6A gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at